Bottom line
SPLB vs MYCJ: the short answer
SPLB (State Street(R) SPDR(R) Portfolio Long Term Corporate Bond ETF) and MYCJ (State Street(R) My2030 Corporate Bond ETF) are both etfs.
But SPLB is far broader, holding 2,951 positions to 192 for MYCJ, so beyond the top names it adds exposure MYCJ doesn't have.
SPLB is cheaper at 0.04% vs 0.15% — a difference of $11 a year per $10,000 invested.
Updated Nov 19, 2026
SPLB vs MYCJ side by side
| SPLB | MYCJ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | SPDR (State Street) |
| Category | Corporate Bond | Corporate Bond |
| Expense ratio | 0.04% | 0.15% |
| Annual cost per $10k | $4 | $15 |
| 10-yr cost on $10k (prospectus) | $51 | $192 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +7.1% | — |
| 5-yr return (annualized) | −3.1% | — |
| 10-yr return (annualized) | +3.3% | — |
| Best quarter | +13.8% | — |
| Worst quarter | −12.8% | — |
| Net assets (fund) | $1.2B | $39.6M |
| Number of holdings | 2,951 | 192 |
| Portfolio turnover | 26% | 19% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
1 of SPLB's top 25 holdings also appear in MYCJ's top 25.
| Holding | SPLB | MYCJ |
|---|---|---|
| State Street Global Advisors | 2.31% | 8.26% |
Source: SEC Form N-PORT
SPLB top 10
- State Street Global Advisors — 2.31%
- Anheuser-busch Co/inbev — 0.35%
- Cvs Health Corp — 0.34%
- Amazon.com Inc — 0.31%
- Meta Platforms Inc — 0.28%
- Charter Comm Opt Llc/cap — 0.28%
- Meta Platforms Inc — 0.27%
- Broadcom Inc — 0.26%
- Meta Platforms Inc — 0.26%
- Pfizer Investment Enter — 0.26%
MYCJ top 10
- State Street Global Advisors — 8.26%
- Boeing Co — 2.58%
- T-mobile USA Inc — 2.31%
- Anheuser-busch Inbev Wor — 2.29%
- Cvs Health Corp — 1.88%
- Energy Transfer Lp — 1.83%
- Bat Capital Corp — 1.69%
- Viatris Inc — 1.57%
- Hca Inc — 1.54%
- At&t Inc — 1.50%
FAQ
What is the difference between SPLB and MYCJ?
Which is cheaper, SPLB or MYCJ?
Should I own both SPLB and MYCJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.